{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:59:29Z","timestamp":1785214769238,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Top Talent of Changzhou \u201cThe 14th Five-Year Plan\u201d High-Level Health Talents Training Project"},{"name":"Major Science and Technology Project of Changzhou Municipal Health Commission","award":["ZD202418"],"award-info":[{"award-number":["ZD202418"]}]},{"name":"General project of Jiangsu Provincial Health Commission","award":["H2023131"],"award-info":[{"award-number":["H2023131"]}]},{"name":"Changzhou Key Laboratory of Maternal and Child Health Medicine","award":["CM20240013"],"award-info":[{"award-number":["CM20240013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00856-0","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:44:39Z","timestamp":1762922679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fetal fractions mediate the association between total cell-free DNA and preeclampsia risk in a non-invasive prenatal testing cohort"],"prefix":"10.1186","volume":"19","author":[{"given":"Bin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"5","key":"856_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8401","volume":"4","author":"Y Yang","year":"2021","unstructured":"Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia, prevalence. Risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4(5):e218401. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8401.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"856_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00839-w","volume":"11","author":"AD Mou","year":"2021","unstructured":"Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339. https:\/\/doi.org\/10.1038\/s41598-021-00839-w.","journal-title":"Sci Rep"},{"issue":"9","key":"856_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093121","volume":"14","author":"P Palmiero","year":"2025","unstructured":"Palmiero P, Caretto P, Ciccone MM, Maiello M. Long-term cardiovascular risk and maternal history of pre-eclampsia. J Clin Med. 2025;14(9):3121. https:\/\/doi.org\/10.3390\/jcm14093121.","journal-title":"J Clin Med"},{"issue":"1","key":"856_CR4","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/JOE-16-0340","volume":"232","author":"DS Boeldt","year":"2017","unstructured":"Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol. 2017;232(1):R27\u201344. https:\/\/doi.org\/10.1530\/JOE-16-0340.","journal-title":"J Endocrinol"},{"issue":"2S","key":"856_CR5","doi-asserted-by":"publisher","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","volume":"226","author":"P Chaemsaithong","year":"2022","unstructured":"Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2S):S1071\u201397. https:\/\/doi.org\/10.1016\/j.ajog.2020.07.020.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"856_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.5603\/GP.a2020.0133","volume":"91","author":"S Kozlowski","year":"2020","unstructured":"Kozlowski S, Zgliczynska M, Kosinska-Kaczynska K. Biomarkers of angiogenesis in twin gestations and the risk of preeclampsia - review of the current literature. Ginekol Pol. 2020;91(12):773\u20136. https:\/\/doi.org\/10.5603\/GP.a2020.0133.","journal-title":"Ginekol Pol"},{"issue":"2","key":"856_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/uog.23531","volume":"57","author":"Z Benk\u0151","year":"2021","unstructured":"Benk\u0151 Z, Wright A, Rehal A, Cimpoca B, Syngelaki A, Delgado JL. Prediction of pre\u2010eclampsia in twin pregnancy by maternal factors and biomarkers at 11\u201313\u2009weeks\u2019 gestation: data from EVENTS trial. Ultrasound Obstet Gynecol. 2021;57(2):257\u201365. https:\/\/doi.org\/10.1002\/uog.23531.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"SupplSuppl","key":"856_CR8","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","volume":"35","author":"ES Taglauer","year":"2014","unstructured":"Taglauer ES, Wilkins-Haug L, Bianchi DW. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta. 2014;35(SupplSuppl):S64\u20138. https:\/\/doi.org\/10.1016\/j.placenta.2013.11.014.","journal-title":"Placenta"},{"key":"856_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clinbiochem.2019.07.001","volume":"71","author":"X Yuan","year":"2019","unstructured":"Yuan X, Zhou L, Zhang B, Wang H, Jiang J, Yu B. Early second-trimester plasma cell free DNA levels with subsequent risk of pregnancy complications. Clin Biochem. 2019;71:46\u201351. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.07.001.","journal-title":"Clin Biochem"},{"key":"856_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.preghy.2020.07.015","volume":"22","author":"X Yuan","year":"2020","unstructured":"Yuan X, Zhou L, Zhang B, Wang H, Yu B, Xu J. Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes. Pregnancy Hypertens. 2020;22:101\u20138. https:\/\/doi.org\/10.1016\/j.preghy.2020.07.015.","journal-title":"Pregnancy Hypertens"},{"key":"856_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1011366","volume":"9","author":"J Li","year":"2022","unstructured":"Li J, Gu X, Wei Y, Tao Y, Zhai B, Peng C, et al. Correlation of low fetal fraction of cell-free DNA at the early second-trimester and pregnancy complications related to placental dysfunction in twin pregnancy. Front Med Lausanne. 2022;9:1011366. https:\/\/doi.org\/10.3389\/fmed.2022.1011366.","journal-title":"Front Med Lausanne"},{"issue":"2","key":"856_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ajog.2023.12.008","volume":"231","author":"EC Becking","year":"2024","unstructured":"Becking EC, Scheffer PG, Henrichs J, Bax CJ, Crombag NMTH, Weiss MM, et al. Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women. Am J Obstet Gynecol. 2024;231(2):244. https:\/\/doi.org\/10.1016\/j.ajog.2023.12.008.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"856_CR13","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG practice Bulletin, number 222. Obstet Gynecol. 2020;135(6):e237\u201360. https:\/\/doi.org\/10.1097\/AOG.0000000000003891.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"856_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jdi.12688","volume":"9","author":"XS Yuan","year":"2018","unstructured":"Yuan XS, Shi H, Wang HY, Yu B, Jiang J. Ficolin-3\/adiponectin ratio for the prediction of gestational diabetes mellitus in pregnant women. J Diabetes Investig. 2018;9(2):403\u201310. https:\/\/doi.org\/10.1111\/jdi.12688.","journal-title":"J Diabetes Investig"},{"issue":"3","key":"856_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100838","volume":"5","author":"R Horgan","year":"2023","unstructured":"Horgan R, Bitas C, Abuhamad A. Intrahepatic cholestasis of pregnancy: a comparison of society for Maternal-Fetal medicine and the Royal college of obstetricians and gynaecologists\u2019 guidelines. Am J Obstet Gynecol MFM. 2023;5(3):100838. https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100838.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"856_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1067\/mob.2001.109594","volume":"184","author":"XY Zhong","year":"2001","unstructured":"Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184(3):414\u20139. https:\/\/doi.org\/10.1067\/mob.2001.109594.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"856_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000236355","volume":"26","author":"M Al Nakib","year":"2009","unstructured":"Al Nakib M, Desbri\u00e8re R, Bonello N, Bretelle F, Boubli L, Gabert J, et al. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther. 2009;26(1):24\u20138. https:\/\/doi.org\/10.1159\/000236355.","journal-title":"Fetal Diagn Ther"},{"key":"856_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-10-120","volume":"10","author":"L Lazar","year":"2009","unstructured":"Lazar L, Rig\u00f3 J Jr, Nagy B, Balogh K, Mak\u00f3 V, Cervenak L, et al. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet. 2009;10:120. https:\/\/doi.org\/10.1186\/1471-2350-10-120.","journal-title":"BMC Med Genet"},{"issue":"6","key":"856_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1515\/CCLM.2010.160","volume":"48","author":"S Galbiati","year":"2010","unstructured":"Galbiati S, Causarano V, Pinzani P, Francesca S, Orlando C, Smid M, et al. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy. Clin Chem Lab Med. 2010;48(6):791\u20134. https:\/\/doi.org\/10.1515\/CCLM.2010.160.","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"856_CR20","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/ajh\/hpt187","volume":"26","author":"ML Miranda","year":"2013","unstructured":"Miranda ML, Macher HC, Mu\u00f1oz-Hern\u00e1ndez R, Vallejo-Vaz A, Moreno-Luna R, Villar J, et al. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome. Am J Hypertens. 2013;26(12):1377\u201380. https:\/\/doi.org\/10.1093\/ajh\/hpt187.","journal-title":"Am J Hypertens"},{"issue":"9","key":"856_CR21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.placenta.2015.07.003","volume":"36","author":"F Salvianti","year":"2015","unstructured":"Salvianti F, Inversetti A, Smid M, Valsecchi L, Candiani M, Pazzagli M, et al. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia. Placenta. 2015;36(9):996\u20131001. https:\/\/doi.org\/10.1016\/j.placenta.2015.07.003.","journal-title":"Placenta"},{"issue":"4","key":"856_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000444524","volume":"40","author":"SY Kim","year":"2016","unstructured":"Kim SY, Kim HJ, Park SY, Han YJ, Choi JS, Ryu HM. Early prediction of hypertensive disorders of pregnancy using cell-free fetal DNA, cell-free total DNA, and biochemical markers. Fetal Diagn Ther. 2016;40(4):255\u201362. https:\/\/doi.org\/10.1159\/000444524.","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"856_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40291-015-0184-x","volume":"20","author":"RM AbdelHalim","year":"2016","unstructured":"AbdelHalim RM, Ramadan DI, Zeyada R, Nasr AS, Mandour IA. Circulating maternal total cell-free DNA, cell-free fetal DNA and soluble endoglin levels in preeclampsia: predictors of adverse fetal outcome?\u00a0A cohort study. Mol Diagn Ther. 2016;20(2):135\u201349. https:\/\/doi.org\/10.1007\/s40291-015-0184-x.","journal-title":"Mol Diagn Ther."},{"issue":"7","key":"856_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ajh\/hpx024","volume":"30","author":"R Mu\u00f1oz-Hern\u00e1ndez","year":"2017","unstructured":"Mu\u00f1oz-Hern\u00e1ndez R, Medrano-Campillo P, Miranda ML, Macher HC, Praena-Fern\u00e1ndez JM, Vallejo-Vaz AJ, et al. Total and fetal circulating cell-free DNA, angiogenic, and antiangiogenic factors in preeclampsia and HELLP syndrome. Am J Hypertens. 2017;30(7):673\u201382. https:\/\/doi.org\/10.1093\/ajh\/hpx024.","journal-title":"Am J Hypertens"},{"issue":"4","key":"856_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/10641955.2017.1385794","volume":"36","author":"S Eche","year":"2017","unstructured":"Eche S, Mackraj I, Moodley J. Circulating fetal and total cell-free DNA, and sHLA-G in black South African women with gestational hypertension and pre-eclampsia. Hypertens Pregnancy. 2017;36(4):295\u2013301. https:\/\/doi.org\/10.1080\/10641955.2017.1385794.","journal-title":"Hypertens Pregnancy"},{"issue":"7","key":"856_CR26","doi-asserted-by":"publisher","first-page":"e0200360","DOI":"10.1371\/journal.pone.0200360","volume":"13","author":"T Rafaeli-Yehudai","year":"2018","unstructured":"Rafaeli-Yehudai T, Imterat M, Douvdevani A, Tirosh D, Benshalom-Tirosh N, Mastrolia SA, et al. Maternal total cell-free DNA in preeclampsia and fetal growth restriction: evidence of differences in maternal response to abnormal implantation. PLoS ONE. 2018;13(7):e0200360. https:\/\/doi.org\/10.1371\/journal.pone.0200360.","journal-title":"PLoS ONE"},{"issue":"2","key":"856_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020564","volume":"22","author":"LM Amaral","year":"2021","unstructured":"Amaral LM, Sandrim VC, Kutcher ME, Spradley FT, Cavalli RC, Tanus-Santos JE, et al. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes. Int J Mol Sci. 2021;22(2):564. https:\/\/doi.org\/10.3390\/ijms22020564.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"856_CR28","doi-asserted-by":"publisher","first-page":"e021477","DOI":"10.1161\/JAHA.121.021477","volume":"10","author":"TR Kolarova","year":"2021","unstructured":"Kolarova TR, Gammill HS, Nelson JL, Lockwood CM, Shree R. At preeclampsia Diagnosis, total Cell-Free DNA concentration is elevated and correlates with disease severity. J Am Heart Assoc. 2021;10(15):e021477. https:\/\/doi.org\/10.1161\/JAHA.121.021477.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"856_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ajog.2024.02.299","volume":"231","author":"A Khalil","year":"2024","unstructured":"Khalil A, Bellesia G, Norton ME, Jacobsson B, Haeri S, Egbert M, et al. The role of cell-free DNA biomarkers and patient data in the early prediction of preeclampsia: an artificial intelligence model. Am J Obstet Gynecol. 2024;231(5):554. https:\/\/doi.org\/10.1016\/j.ajog.2024.02.299.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"856_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/uog.14671","volume":"45","author":"DL Rolnik","year":"2015","unstructured":"Rolnik DL, O\u2019Gorman N, Fiolna M, van den Boom D, Nicolaides KH, Poon LC. Maternal plasma cell-free DNA in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2015;45(1):106\u201311. https:\/\/doi.org\/10.1002\/uog.14671.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"856_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0035-1570383","volume":"34","author":"RM Silver","year":"2017","unstructured":"Silver RM, Myatt L, Hauth JC, Leveno KJ, Peaceman AM, Ramin SM, et al. Cell-Free total and fetal DNA in first trimester maternal serum and subsequent development of preeclampsia. Am J Perinatol. 2017;34(2):191\u20138. https:\/\/doi.org\/10.1055\/s-0035-1570383.","journal-title":"Am J Perinatol"},{"issue":"1","key":"856_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68842-1","volume":"10","author":"DW Kwak","year":"2020","unstructured":"Kwak DW, Kim SY, Kim HJ, Lim JH, Kim YH, Ryu HM. Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction. Sci Rep. 2020;10(1):11848. https:\/\/doi.org\/10.1038\/s41598-020-68842-1.","journal-title":"Sci Rep"},{"issue":"5","key":"856_CR33","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s43032-021-00466-w","volume":"28","author":"\u0410\u041e Karapetian","year":"2021","unstructured":"Karapetian \u0410\u041e, Baev \u041eR, Sadekova \u0410\u0410, Krasnyi \u0410\u041c, Sukhikh GT. Cell-free foetal DNA as a useful marker for preeclampsia prediction. Reprod Sci. 2021;28(5):1563\u20139. https:\/\/doi.org\/10.1007\/s43032-021-00466-w.","journal-title":"Reprod Sci"},{"issue":"3","key":"856_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00404-024-07638-4","volume":"310","author":"I Sapantzoglou","year":"2024","unstructured":"Sapantzoglou I, Giourga M, Pergialiotis V, Mantzioros R, Daskalaki MA, Papageorgiou D, et al. Low fetal fraction and adverse pregnancy outcomes- systematic review of the literature and metanalysis. Arch Gynecol Obstet. 2024;310(3):1343\u201354. https:\/\/doi.org\/10.1007\/s00404-024-07638-4.","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"856_CR35","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00404-024-07905-4","volume":"311","author":"S Arbuzova","year":"2025","unstructured":"Arbuzova S, Cuckle H. Maternal cell-free DNA in early pregnancy for preeclampsia screening: a systematic review. Arch Gynecol Obstet. 2025;311(5):1249\u201358. https:\/\/doi.org\/10.1007\/s00404-024-07905-4.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"856_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/uog.18993","volume":"52","author":"DL Rolnik","year":"2018","unstructured":"Rolnik DL, da Silva Costa F, Lee TJ, Schmid M, McLennan AC. Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia. Ultrasound Obstet Gynecol. 2018;52(6):722\u20137. https:\/\/doi.org\/10.1002\/uog.18993.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"856_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","volume":"16","author":"KD Gerson","year":"2019","unstructured":"Gerson KD, Truong S, Haviland MJ, O\u2019Brien BM, Hacker MR, Spiel MH. Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy. Pregnancy Hypertens. 2019;16:148\u201353. https:\/\/doi.org\/10.1016\/j.preghy.2019.04.002.","journal-title":"Pregnancy Hypertens"},{"issue":"10","key":"856_CR38","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/pd.6034","volume":"41","author":"EC Becking","year":"2021","unstructured":"Becking EC, Wirjosoekarto SAM, Scheffer PG, Huiskes JVM, Remmelink MJ, Sistermans EA. Low fetal fraction in cell\u2010free DNA testing is associated with adverse pregnancy outcome: analysis of a subcohort of the TRIDENT\u20102 study. Prenat Diagn. 2021;41(10):1296\u2013304. https:\/\/doi.org\/10.1002\/pd.6034.","journal-title":"Prenat Diagn"},{"issue":"25","key":"856_CR39","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1080\/14767058.2021.1879043","volume":"35","author":"I Sapantzoglou","year":"2022","unstructured":"Sapantzoglou I, Gallardo Arozena M, Dragoi V, Akolekar R, Nicolaides KH, Syngelaki A. Fetal fraction of cell free DNA in screening for hypertensive disorders at 11\u201313 weeks. J Matern Fetal Neonatal Med. 2022;35(25):5363\u20138. https:\/\/doi.org\/10.1080\/14767058.2021.1879043.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"856_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0038-1667374","volume":"36","author":"WR Bender","year":"2019","unstructured":"Bender WR, Koelper NC, Sammel MD, Dugoff L. Association of fetal fraction of cell-free DNA and hypertensive disorders of pregnancy. Am J Perinatol. 2019;36(3):311\u20136. https:\/\/doi.org\/10.1055\/s-0038-1667374.","journal-title":"Am J Perinatol"},{"issue":"11","key":"856_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.18502\/ijrm.v22i11.17824","volume":"22","author":"M Aryavand","year":"2024","unstructured":"Aryavand M, Nurzadeh M, Ghaemi M, Eskandari Delfan S, Marsoosi V. The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: a cohort study. Int J Reprod Biomed. 2024;22(11):919\u201326. https:\/\/doi.org\/10.18502\/ijrm.v22i11.17824.","journal-title":"Int J Reprod Biomed"},{"issue":"1","key":"856_CR42","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1055\/s-0040-1721674","volume":"11","author":"Y Wu","year":"2021","unstructured":"Wu Y, Werlang A, Cheng W, Lanes A, Wen SW, Walker M. Association between levels of total Cell-Free DNA and development of Preeclampsia-A literature review. AJP Rep. 2021;11(1):e38\u201348. https:\/\/doi.org\/10.1055\/s-0040-1721674.","journal-title":"AJP Rep"},{"issue":"10","key":"856_CR43","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/pd.6028","volume":"41","author":"PG Scheffer","year":"2021","unstructured":"Scheffer PG, Wirjosoekarto SAM, Becking EC, Weiss MM, Bax CJ, Oepkes D, et al. Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review. Prenat Diagn. 2021;41(10):1287\u201395. https:\/\/doi.org\/10.1002\/pd.6028.","journal-title":"Prenat Diagn"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00856-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00856-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00856-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:44:40Z","timestamp":1762922680000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00856-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00856-0","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethical Committee of Changzhou Maternal and Child Health Care Hospital (ZD201803). Owing to the anonymous data recorded in the present study, the requirement for written informed consent was waived by the Ethical Committee of Changzhou Maternal and Child Health Care Hospital. All methods in this study were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}